CDC Changes Mask Rules for Fully Vaccinated People Using Public Transportation
Masks are no longer necessary in outdoor waiting areas or open-air seating for fully vaccinated people who use public transportation.
Vaccines
Novavax COVID-19 Vaccine Highly Effective in Pivotal Phase 3 Trial
The pivotal phase 3 PREVENT-19 trial evaluated the efficacy, safety and immunogenicity of NVX-CoV2373 in 29,960 participants 18 years of age and older in the US and Mexico.
FDA Authorizes Shelf Life Extension of Janssen/Johnson & Johnson COVID-19 Vaccine
The extension was based on data from ongoing stability assessment studies.
COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization
A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of a World Trade Organization (WTO) panel.
Catch-Up Vaccinations for Children, Teens Lagging Behind
Catch-up vaccinations for routine childhood and adolescent vaccinations are lagging behind after a decline during March to May 2020.
Novavax COVID-19 Vaccine Shines in Latest Trial
Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its COVID-19 vaccine, announced Monday that its two-shot regimen was more than 90% effective overall in a trial that unfolded even as more contagious variants emerged.
Vaccinations More Urgent Following Delta Variant Present in the US
The highly contagious coronavirus variant that brought India to its knees this spring now accounts for 6% of new cases in the United States, the Biden administration said Tuesday.
Expiration Date Looming for Millions of Janssen/Johnson & Johnson COVID-19 Vaccine Doses
US federal and state health officials are trying to administer as many doses as possible of the Johnson & Johnson COVID-19 vaccine as millions of unused shots are set to expire this month.
Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID-19
A real-world study shows that even when people who get the Pfizer and Moderna COVID-19 vaccines do have “breakthrough” infections, those illnesses are mild.
Moderna COVID-19 Vaccine Safe, Effective in Adolescents
The TeenCOVE study (ClinicalTrials.gov: NCT04649151) included over 3700 US adolescents aged 12 to less than 18 years.
- Loading...
Loading...
Next post in General Pain
Loading... 
Loading...